(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.06%) $0.927
(0.31%) $10.87
(0.06%) $0.793
(-0.31%) $92.29
@ $24.99
Issued: 13 Feb 2024 @ 15:43
Return: -64.07%
Previous signal: Feb 13 - 09:30
Previous signal:
Return: 0.73 %
Live Chart Being Loaded With Signals
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases...
Stats | |
---|---|
Today's Volume | 608 335 |
Average Volume | 1.26M |
Market Cap | 312.48M |
EPS | $0 ( 2024-03-12 ) |
Next earnings date | ( $-0.800 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.94 |
ATR14 | $0.0200 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-31 | Ho William | Buy | 75 000 | Employee Stock Option (right to buy) |
2024-01-31 | Young Rodney Kb | Buy | 90 000 | Employee Stock Option (right to buy) |
2024-01-31 | Brockstedt Dirk G. | Buy | 75 000 | Employee Stock Option (right to buy) |
2024-01-31 | Wong Brian Russell | Buy | 275 000 | Employee Stock Option (right to buy) |
2024-01-05 | Brockstedt Dirk G. | Sell | 898 | Common Stock |
INSIDER POWER |
---|
94.29 |
Last 100 transactions |
Buy: 3 717 989 | Sell: 63 895 |
Volume Correlation
Rapt Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
RDUS | 0.903 |
ICON | 0.901 |
ATCX | 0.9 |
SYKE | 0.898 |
PAE | 0.889 |
BRACU | 0.886 |
RCON | 0.884 |
CLBT | 0.884 |
ABNB | 0.878 |
DKNG | 0.876 |
10 Most Negative Correlations | |
---|---|
VIEW | -0.886 |
SBBP | -0.863 |
TUEM | -0.855 |
LGHL | -0.855 |
ARDS | -0.848 |
LCAP | -0.844 |
RPTX | -0.839 |
AHPI | -0.839 |
MTEX | -0.838 |
NAKD | -0.838 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rapt Therapeutics Inc Correlation - Currency/Commodity
Rapt Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.55M (0.00 %) |
EPS: | $-3.05 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-323 000 (0.00 %) |
EPS: | $-0.800 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-908 000 (0.00 %) |
EPS: | $-0.820 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-853 000 (0.00 %) |
EPS: | $-0.660 |
Financial Reports:
No articles found.
Rapt Therapeutics Inc
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators